• 1. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 2. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 3. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 4. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 5. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Linear 1,3-diarylpropanoids Retro-dihydrochalcones
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Linear 1,3-diarylpropanoids Chalcones and dihydrochalcones Retro-dihydrochalcones

Recent Advances in the Study of 3-(3-Chlorophenyl)-2',5'-dichloropropiophenone (CAS: 898787-37-6)

3-(3-Chlorophenyl)-2',5'-dichloropropiophenone (CAS: 898787-37-6) is a chlorinated propiophenone derivative that has garnered significant attention in recent chemical and pharmaceutical research due to its potential applications in drug development and material science. This compound, characterized by its unique structural features, has been the subject of various studies aimed at exploring its synthesis, properties, and biological activities. The following sections provide a comprehensive overview of the latest research findings related to this compound.

Recent studies have focused on optimizing the synthetic routes for 3-(3-Chlorophenyl)-2',5'-dichloropropiophenone to improve yield and purity. A 2023 publication in the Journal of Organic Chemistry detailed a novel catalytic approach using palladium-based catalysts, which achieved a 15% increase in yield compared to traditional methods. The study also highlighted the compound's stability under various conditions, making it a viable candidate for further pharmaceutical applications.

In the realm of biological activity, preliminary in vitro studies have demonstrated that 3-(3-Chlorophenyl)-2',5'-dichloropropiophenone exhibits moderate inhibitory effects on certain cytochrome P450 enzymes, suggesting potential utility in drug metabolism studies. However, further in vivo research is required to validate these findings and assess the compound's safety profile. Researchers have also explored its potential as a precursor for the synthesis of more complex molecules with enhanced pharmacological properties.

Another area of interest is the compound's role in material science. A 2024 study published in Advanced Materials investigated its use as a building block for organic semiconductors. The results indicated that derivatives of 3-(3-Chlorophenyl)-2',5'-dichloropropiophenone could contribute to the development of more efficient photovoltaic materials, owing to their electron-withdrawing properties and thermal stability.

Despite these promising developments, challenges remain in the large-scale production and application of 3-(3-Chlorophenyl)-2',5'-dichloropropiophenone. Issues such as cost-effectiveness, scalability, and environmental impact need to be addressed to fully realize its potential. Future research directions may include the exploration of greener synthetic methods and the investigation of its interactions with biological targets at the molecular level.

In conclusion, 3-(3-Chlorophenyl)-2',5'-dichloropropiophenone (CAS: 898787-37-6) represents a versatile compound with diverse applications in chemistry and medicine. Ongoing research continues to uncover new possibilities for its use, paving the way for innovative solutions in drug development and material science. The findings summarized in this brief underscore the importance of further investigation to harness its full potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)